BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 112 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,956 | +12.9% | 80,124 | -25.6% | 0.00% | 0.0% |
| Q1 2023 | $203,655 | -21.2% | 107,754 | -25.0% | 0.00% | 0.0% |
| Q4 2022 | $258,595 | -26.3% | 143,664 | -30.9% | 0.00% | 0.0% |
| Q3 2022 | $351,000 | -45.2% | 207,893 | -20.2% | 0.00% | -50.0% |
| Q2 2022 | $641,000 | -43.2% | 260,484 | -36.1% | 0.00% | -33.3% |
| Q1 2022 | $1,129,000 | -29.6% | 407,423 | +35.4% | 0.00% | 0.0% |
| Q4 2021 | $1,604,000 | -36.1% | 301,002 | +1.4% | 0.00% | -50.0% |
| Q3 2021 | $2,511,000 | -50.3% | 296,806 | -28.3% | 0.01% | -45.5% |
| Q2 2021 | $5,049,000 | +69.5% | 414,187 | +237.4% | 0.01% | +37.5% |
| Q1 2021 | $2,978,000 | -26.3% | 122,766 | -2.7% | 0.01% | -33.3% |
| Q4 2020 | $4,043,000 | – | 126,140 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |